Publisher: Eurasian Harm Reduction Network (EHRN)
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) adopted the Eligibility and Counterpart Financing Policy, designed to optimize funding based on economic and health indicators in 2013. Eligibility was determined by income level and disease burden in a specific country context. The rationale behind this approach was that relatively well performing economies, in particular with moderate burdens of disease, can and should assume responsibilities for funding programs addressing these diseases. With the introduction of the New Funding Model (NFM), the Global Fund’s allocations for 2014-2017 for countries in Eastern Europe and Central Asia (EECA), many of which are middle-income countries, have been reduced by 15% in comparison with 2010-2013 disbursements. The Global Fund has been gradually scaling down or fully withdrawing its support from many countries in EECA.
This report aims to: 1) Assess the readiness of countries in the region for transition from Global Fund funding for HIV responses to national funding; and/or 2) Experience of countries related to the process of transition planning and implementation. Eleven countries with relatively diverse economic and health landscapes were selected for this analysis.